NEMUS Bioscience - Possible Entry for medical pain therapyNMUS
About: NEMUS Bioscience, Inc. ( NMUS ) , focused on the development of cannabinoid-based therapeutics to address global medical indications, especially those of unmet medical need.
Entry better on 4h / 1d vs 1w chart here and another CBD stock missed entry for self note.
Watching to see if breakout from current level. Future entry TBD. Watch out for random "cannabinoid" being said in your meetings today with TESLA. @pokethebear
I do not advocate THC use and consider the current opioid epidemic to be another on-ramp for alternative break-though medicine. Lipitor to Pfizer, Embrel to AMGEN? 10-1 baggers/3 yr focus. #pharmaindustry. 65% insider owned & no sells on record.
